News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Turtle Cameron
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
3
| Turtle Cameron (Chief Operating Officer) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 01/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2020 |
4
| Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 10,937 shares
@ $69.3361, valued at
$758.3k
Sold 8,563 shares
@ $69.9352, valued at
$598.9k
Exercised 7,500 options to buy
@ $17, valued at
$127.5k
Exercised 6,000 options to buy
@ $0.34, valued at
$2k
Exercised 6,000 options to buy
@ $0.16, valued at
$960 |
|
| 12/16/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 3,756 shares
@ $110.2906, valued at
$414.3k
Sold 7,600 shares
@ $111.3075, valued at
$845.9k
Sold 11,445 shares
@ $112.1903, valued at
$1.3M
Sold 3,493 shares
@ $112.9657, valued at
$394.6k
Exercised 4,451 options to buy
@ $17, valued at
$75.7k
Exercised 21,843 options to buy
@ $13.2, valued at
$288.3k
|
|
| 11/25/2020 |
4
| Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 4,258 shares
@ $47.0026, valued at
$200.1k
Sold 742 shares
@ $47.2288, valued at
$35k
Exercised 4,258 options to buy
@ $17, valued at
$72.4k
Exercised 742 options to buy
@ $17, valued at
$12.6k
|
|
| 11/13/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 3,005 shares
@ $73.564, valued at
$221.1k
Sold 9,497 shares
@ $74.7457, valued at
$709.9k
Sold 908 shares
@ $75.2286, valued at
$68.3k
Gifted 1,500 shares
@ $0 |
|
| 11/09/2020 |
4
| Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 2,500 shares
@ $42.0499, valued at
$105.1k
Exercised 2,500 options to buy
@ $17, valued at
$42.5k
|
|
| 11/03/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 9,145 shares
@ $70.4438, valued at
$644.2k
Sold 3,146 shares
@ $71.4167, valued at
$224.7k
Sold 209 shares
@ $72.0961, valued at
$15.1k
Exercised 5,000 options to buy
@ $13.2, valued at
$66k
Exercised 2,500 options to buy
@ $17, valued at
$42.5k
|
|
| 10/02/2020 |
4
| Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 12,442 shares
@ $37.5945, valued at
$467.8k
Sold 2,058 shares
@ $38.2444, valued at
$78.7k
Exercised 2,500 options to buy
@ $17, valued at
$42.5k
Exercised 6,000 options to buy
@ $0.16, valued at
$960
Exercised 6,000 options to buy
@ $0.34, valued at
$2k
|
|
| 09/22/2020 |
4
| Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 2,500 shares
@ $42.0097, valued at
$105k
Exercised 2,500 options to buy
@ $17, valued at
$42.5k
|
|
| 09/16/2020 |
4
| Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 2,500 shares
@ $37.0607, valued at
$92.7k
Exercised 2,500 options to buy
@ $17, valued at
$42.5k
|
|
| 09/15/2020 |
4
| Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 2,000 shares
@ $35.0235, valued at
$70k
Exercised 2,000 options to buy
@ $0.34, valued at
$680 |
|
| 09/11/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $47, valued at
$117.5k
Exercised 2,500 options to buy
@ $17, valued at
$42.5k
|
|
| 09/02/2020 |
4
| Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 2,745 shares
@ $0 |
|
| 08/05/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 2,800 shares
@ $39.0471, valued at
$109.3k
Sold 6,700 shares
@ $40.2495, valued at
$269.7k
Sold 500 shares
@ $40.8927, valued at
$20.4k
Exercised 5,000 options to buy
@ $13.2, valued at
$66k
|
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 376 shares
@ $41.5735, valued at
$15.6k
|
|
| 05/28/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $47, valued at
$117.5k
Exercised 2,500 options to buy
@ $17, valued at
$42.5k
|
|
| 05/21/2020 |
4
| Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 1,082 options to buy
@ $1.25, valued at
$1.4k
Granted 74,042 options to buy
@ $0.16, valued at
$11.8k
Granted 49,766 options to buy
@ $0.34, valued at
$16.9k
|
|
| 05/05/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 7,750 shares
@ $40.524, valued at
$314.1k
Sold 1,050 shares
@ $41.2253, valued at
$43.3k
Sold 1,180 shares
@ $42.5597, valued at
$50.2k
Sold 20 shares
@ $43.26, valued at
$865.2
Exercised 5,000 options to buy
@ $13.2, valued at
$66k
|
|
| 04/29/2020 |
4
| Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 2,000 shares
@ $32.0138, valued at
$64k
Exercised 2,000 options to buy
@ $17, valued at
$34k
|
|
| 04/10/2020 |
4
| Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 8,000 shares
@ $27.0447, valued at
$216.4k
Exercised 8,000 options to buy
@ $17, valued at
$136k
|
|
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 5,289 shares
@ $53.3189, valued at
$282k
Sold 7,211 shares
@ $53.8949, valued at
$388.6k
Exercised 5,000 options to buy
@ $13.2, valued at
$66k
Exercised 2,500 options to buy
@ $17, valued at
$42.5k
|
|
| 01/10/2020 |
4
| Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 8,005 shares
@ $34.1713, valued at
$273.5k
Sold 4,802 shares
@ $34.7084, valued at
$166.7k
Exercised 10,000 options to buy
@ $17, valued at
$170k
|
|
| 12/10/2019 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 400 shares
@ $56.84, valued at
$22.7k
Sold 700 shares
@ $58.2771, valued at
$40.8k
Sold 8,900 shares
@ $59.4294, valued at
$528.9k
Exercised 10,000 options to buy
@ $13.2, valued at
$132k
|
|
| 11/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2019 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 4,357 shares
@ $41.51, valued at
$180.9k
Sold 643 shares
@ $42.09, valued at
$27.1k
|
|
| 07/03/2019 |
4
| Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Exercised 3,368 options to buy
@ $0
Exercised 9,262 options to buy
@ $0 |
|
| 06/27/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/06/2019 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 1,081 shares
@ $12.01, valued at
$13k
Granted 1,769 shares
@ $12.01, valued at
$21.2k
Sold 6,700 shares
@ $31.33, valued at
$209.9k
Sold 3,300 shares
@ $32.27, valued at
$106.5k
|
|
| 11/07/2018 |
3
| Turtle Cameron (Chief Business Officer) has filed a Form 3 on Eidos Therapeutics, Inc. |
|
|